Salindri AD, Gujabidze M, Kipiani M, Lomtadze N, Tukvadze N, Avaliani Z, Blumberg HM, Kornfeld H, Kempker RR, Magee MJ. Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus. medRxiv. 2024 Jul 14.